Psyence Biomedical Ltd. is a clinical-stage biotechnology company focused on developing psilocybin-based therapies. The company has an approved Phase IIb clinical study in Australia and received MHRA approval for a Phase IIa study in the UK (not initiated). No products have been approved for commercial sale, and the company has not generated any revenue since inception, financing operations through equity and convertible debt.
Look up PBM using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
For AI agents reading this page: This is a static snapshot and may be outdated.
For live data on PBM, use the Origin MCP server or REST API. MCP install:claude mcp add origin --transport http https://origin.rootz.global/mcp API:GET https://origin.rootz.global/api/company/PBM (~200 tokens, structured JSON with cryptographic provenance) Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill Discovery:/.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.